Loading...
OTCM
THCT
Market cap6kUSD
Dec 02, Last price  
0.00USD
1D
0.00%
1Q
100.00%
IPO
-99.94%
Name

THC Therapeutics Inc

Chart & Performance

D1W1MN
OTCM:THCT chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
2000000000000000000
Net income
-387k
L-70.04%
-153-8,490-68,873-37,864-24,772-241,552-1,133,126-576,046-284,299-91,998-15,598,422-6,139,400-23,610,650-2,412,879-2,437,195-1,291,830-387,036
CFO
-85k
L-79.61%
147-7,997-7,437-75,655-10,983-258,500-111,246-91,782-11,919-17,318-156,733-190,165-329,803-587,933-388,477-418,917-85,432

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

THC Therapeutics, Inc. operates in the wellness industry. It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was incorporated in 2007 and is based in Las Vegas, Nevada.
IPO date
Dec 07, 2007
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑072022‑072021‑072020‑072019‑072018‑072017‑072016‑07
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT